-
CK2-Dependent Phosphorylation Regulates Ceramide Synthase in
2026-04-25
This study uncovers a phosphorylation-dependent mechanism by which casein kinase 2 (CK2) modulates the activity and stability of the ceramide synthase LOH2 in Arabidopsis. These findings clarify how plant sphingolipid biosynthesis and immune responses are fine-tuned, with translational implications for research into cell death and stress signaling.
-
Species-Specific PK of HD56 Prodrug: Humanized Mice as Predi
2026-04-24
This study establishes the crucial role of humanized liver mice in predicting human pharmacokinetics and metabolic fate of carboxylate ester prodrugs, focusing on HD56, a prodrug targeting FK506 binding proteins. The findings improve preclinical modeling for neurodegenerative drug development, offering guidance for translational research and compound selection.
-
H-Aggregated NIR-II Fluorophores Enhance Tumor Photothermal
2026-04-24
Yu et al. introduce a lipid nanosystem employing H-aggregated NIR-II fluorophore IR-1061, functionally targeted by an RR9 peptide, to tumor cell membranes for improved photothermal therapy (PTT) and synergistic chemotherapeutic outcomes. This approach enables both high-contrast tumor imaging and robust PTT effect through membrane-localized aggregation, addressing persistent limitations in organic fluorophore-based therapies.
-
CCR7–Notch1 Crosstalk Drives Stemness in MMTV-PyMT Mammary C
2026-04-23
Boyle et al. (2017) reveal a functional interplay between the CCR7 chemokine receptor and Notch1 signaling axes that promotes stemness in mammary tumor cells. This mechanistic insight highlights dual pathway targeting as a promising strategy to inhibit cancer stem cell-driven recurrence in breast cancer.
-
Merbromin as a Mixed-Type Inhibitor of SARS-CoV-2 3CLpro Pro
2026-04-23
This study identifies Merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro) through high-throughput screening and kinetic analysis. The findings clarify Merbromin’s inhibitory mechanism and establish a scaffold for future antiviral drug development targeting coronavirus proteases.
-
Anti-Fibrotic Actions of 1-Phenyl-2-Pentanol in Hepatic Stel
2026-04-22
This article reviews the recent study on 1-Phenyl-2-Pentanol, a natural product from Moringa oleifera, and its anti-fibrotic effects on hepatic stellate cells. The work highlights molecular mechanisms relevant to liver fibrosis inhibition and discusses implications for related research using structurally similar compounds.
-
Comparative Antibacterial Activities of β-Lactam Derivatives
2026-04-22
This article reviews Cullmann et al.'s pivotal 1982 study comparing N-formimidoyl thienamycin (MK0787) with contemporary β-lactam antibiotics, including cefoperazone sodium salt. The findings clarify the relative efficacy of these agents against resistant gram-negative and gram-positive clinical isolates, offering guidance for antimicrobial research and assay design.
-
GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi
2026-04-21
This study reveals that upregulating GLT-1 expression in astrocytes counteracts neuronal apoptosis and cognitive deficits following traumatic brain injury (TBI) by suppressing the CB1-CREB signaling pathway. The findings clarify how endocannabinoid 2-AG elevation after TBI negatively modulates glutamate homeostasis, emphasizing new mechanistic targets for neuroprotection.
-
DrPISA: Enhanced Drug Target Identification via Insoluble Pr
2026-04-21
DrPISA introduces a deep eutectic solvent-assisted workflow that expands thermal proteome profiling to heat-induced aggregates, enabling more sensitive drug target identification. The approach outperforms conventional solubilization methods, offering a scalable means to interrogate insoluble proteome fractions in chemical biology and drug discovery.
-
Puromycin dihydrochloride: Technical Use and Protocol Guidan
2026-04-20
Puromycin dihydrochloride is an aminonucleoside antibiotic used for precise selection of cell lines expressing the pac gene and for dissecting protein synthesis in molecular biology. It is not suited for applications requiring reversible translation inhibition or where cell-type-specific cytotoxicity cannot be controlled. Proper handling, concentration selection, and workflow QC are critical for reproducibility and viability.
-
O-GlcNAcylation Links Wnt Signaling to Bone Anabolism via Gl
2026-04-20
This study uncovers how Wnt3a-driven O-GlcNAcylation at PDK1 modulates glycolytic metabolic flux to promote osteoblast differentiation and bone formation. The findings highlight a previously unrecognized metabolic mechanism underlying Wnt-induced bone anabolism, offering new targets for osteoporosis research and therapeutic development.
-
Ziprasidone Augmentation in Anxious Depression: Efficacy and
2026-04-19
This article reviews a post-hoc analysis of a randomized controlled trial evaluating ziprasidone augmentation for major depressive disorder with comorbid anxiety. The study found that ziprasidone hydrochloride, added to escitalopram, did not provide a clinically significant anxiolytic benefit for patients with anxious depression, though its antidepressant efficacy was similar across subgroups. These findings clarify the therapeutic boundaries of ziprasidone in complex mood disorder presentations.
-
Phenothiazines Boost Macrophage Antibacterial Activity via R
2026-04-18
This study reveals that phenothiazine compounds, including dopamine D2 receptor inhibitors, significantly enhance the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) and autophagy. These findings offer a mechanistic basis for host-directed antibacterial strategies and highlight the translational potential of phenothiazine-based research tools.
-
Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele
2026-04-17
This study introduces a peptide design that leverages dual enzyme responsiveness and zwitterionic self-assembly to achieve high cancer selectivity. The approach enables lysosome-targeted peptide assembly, inducing selective cancer cell death with minimal toxicity to normal tissues, and offers a promising path for precision peptide-based cancer therapeutics.
-
AI-Driven Discovery of Senolytics: Mechanisms, Methods, and
2026-04-16
The reference study introduces a machine learning framework that efficiently identifies novel senolytic compounds by leveraging published screening data, significantly reducing discovery costs. This approach enhances the pipeline for selective elimination of senescent cells, with broad implications for cancer, aging, and translational research.